Dong Zhao

An FDA/CDER perspective on nonclinical testing strategies: Classical toxicology approaches and new approach methodologies (NAMs).

D. Mendrick, Jackye Peretz, R. Wange, 2020, Regulatory toxicology and pharmacology : RTP.

Randomized, placebo-controlled, single-blind phase 1 studies of the safety, tolerability, and pharmacokinetics of BRII-196 and BRII-198, SARS-CoV-2 spike-targeting monoclonal antibodies with an extended half-life in healthy adults

Zheng Zhang, Yang Liu, Ji Ma, 2022, Frontiers in Pharmacology.